Print E-mail
Volume 45, Number 3, June 2012

Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum and AmpC type b-Lactamases


Kochung Tsui, Swee-Siang Wong, Li-Chen Lin, Chim-Ren Tsai, Li-Chun Chen, Cheng-Hua Huang


Received: June 9, 2011    Revised: June 29, 2011    Accepted: July 25, 2011   

 

Corresponding author:

Number 280, Section 4, Ren-Ai Road, Da-An District, Taipei City 10630, Taiwan. E-mail address: dmrlabmed@cgh.org.tw (C.-H. Huang).



 

Background and purpose: 

 Extended-spectrum b-lactamase (ESBL)-producing bacteria coexpressing AmpC type b-lactamase (ACBL) are associated with the laboratory issue of false susceptibility to third-generation cephalosporins. This study was to evaluate laboratory tests and clinical significance of bacteremic isolates of Escherichia coli and Klebsiella pneumoniae with both ESBLand ACBL [dual-type lactamases (DTL)].



 

Methods:

From 2006 to 2009, 78 E coli and 12 pneumoniae bacteremic isolates with reduced susceptibility to cefotaxime (CTX) or ceftazidime (CAZ) were identified and relevant patients’ data were collected for analysis. Phenotypic and genotypic characterizations of these selected isolates were determined by inhibitor-based assays and polymerase chain reactionebased genetic analyses, respectively.



 

Results:

Among the 90 isolates, 47 had DTL production. There was an increasing annual prevalence from 29% in 2006 to 56% in 2009 (pZ0.02). Phenotypic assays had a sensitivity and specificity of 57% (43/76) and 93% (13/14) for ESBL detection and 95% (58/61) and 34% (10/29) for ACBL, respectively. Among the DTL-producing isolates, phenotypic assays yielded a higher false negative rate of ESBL detection than that of ACBL detection (70% versus 6%), while all false negative ESBL results were associated with ESBL genes other than blaCTx-M. The majority of the DTL-producing isolates were in the category of resistance to CTX (47/47, 100%) and CAZ (44/47, 94%) by the Clinical and Laboratory Standards Institute (CLSI) 2010 interpretive criteria, of which many were considered intermediate or fully susceptible to CTX (25/47, 53%) and CAZ (15/47, 32%) by the previous ones (CLSI-2009). The DTL-producing isolates exhibited a lower susceptibility rate to fluoroquinolones, aztreonam, and b-lactam/

lactamase inhibitors than those with either ESBL or ACBL alone. The use of indwelling catheters
or nasogastric tubes was associated with bacteremia due to the DTL isolates, but the mortality rates were not different among those due to isolates with ESBL, ACBL, or both. By multivariate analysis,  Pittsburg bacteremia score and Charlson comorbidity index were the significant predictors for all-cause mortalities.


 

Conclusion:

Bacteremic episodes due to DTL-producing E coli and K pneumoniae became increasingly prevalent and were often associated with coresistance to antibiotics other than b-lactams, but they were not associated with a worse prognosis than those due to ESBL- or ACBL-producing bacteria.



 

Key words:

AmpC b-lactamase; Bacteremia; E coli; ESBL; K pneumoniae